SlideShare a Scribd company logo
1 of 9
Guidelines on ADR reporting
Presented by;
K. Sai Lakshmi
B-Pharmacy, final year,
(2016-2020)
Balaji College of Pharmacy.
A.PATIENT INFORMATION
B.SUSPECTED DRUGS
C.SUSPECTED ADVERSE DRUG
REACTION
D.OTHER MEDICATIONS
E.REPORTER
A. PATIENT INFORMATION;
1.Patient Details
 Patient name or initials: A reporter should mention the name of
the patient or initials of a patient.
For e.g.: Ngawang Dema or ND (whichever is convenient).
 Age at time of event or date of birth: A reporter must report either
the date of birth or age of the patient at the time the event or
reaction occurred.
 Sex: A reporter must mention the gender of the patient.
 Weight: If known, the weight of the patient should be in
kilograms(kg).
2. Relevant tests/Laboratory data
 A reporter must mention any laboratory data (if available).
3. Other Relevant history
 A reporter must mention any relevant history pertaining to the
patient including pre-existing medical conditions
e.g.: Allergies, pregnancy, alcohol use, hepatic or renal dysfunction.
B. SUSPECTED DRUGS;
 It may be one drug or more than one drug.
 The details of suspected medications such as the drug name
(brand or generic name), manufacturer, batch no / lot no, expiry
date, dose used, route used, dates of therapy started and stopped,
and indication of use must be provided by the reporter.
C. SUSPECTED ADVERSE DRUG REACTION;
1. Describe reaction and any treatment given:
 A reporter must briefly describe the event in terms of nature, localization
etc.
For eg; patient developed rash over upper and lower limbs.
 The reporter must be also indicate if any treatment is given againist the
Suspected Adverse Drug Reaction.
 Reporter must also mention if the suspected drugs was withdrawn or
continued.
 Date of reaction started; A reporter must the date on which the reaction
was first occurred.
 Date of reaction stopped; If the reaction recovered, the date on which the
reaction recovered should be reported.
 Outcomes: The reporter must tick the outcomes of the event as;
Recovered- if the patient has recovered from the event
Recovering- if the patient is recovering from the existing adverse event
Continuing-if the patient is continuing to have the symptoms of the adverse
event which occurred.
2. Seriousness of the reaction:
 If any event is serious in nature, a reporter must selected the
appropriate reason for seriousness e.g.:
 Death-if the patient died due to the adverse event
 Hospitalization/prolonged-if the adverse event led to
hospitalization or increased the hospital stay of the patient.
 Life-threatening-if patient was at substantial risk of drying
because of the adverse event.
 Significant Disability-if the adverse event resulted in a
substantial disruption of a person`s ability to conduct normal life
functions.
 Congenital anomaly-if exposure of drug prior to conception or
during pregnancy may have resulted in an adverse outcome in the
child.
 Other medically significant- when the event does not fit the
other outcomes, but the event may put the patient at risk and may
require medical or surgical intervention to prevent one of the other
outcomes.
D. OTHER MEDICATIONS;
 A Reporter should include all the details of concomitant drugs
including self medication, Over the Counter medication, herbal
remedies with therapy dates(start and stop date).
E. REPORTER;
 Name and Professional address: A reporter must mention
his/her name and professional address on the form. The
identity of the reporter will be maintained confidential if
necessary.
 Date of report: Mention the date on which he/she reported the
adverse event.
NOTE: For quality reporting, all the above mentioned fields are
essential. In case of incomplete information, the reporter must
take care that at least mandatory fields are present. Following
are the mandatory fields for a valid case report and are marked
with asterisk on the form:
 Patient information: initials, age at onset of reaction,
gender.
 Suspected adverse reaction: A reaction terms, date of
onset of reaction.
 Suspected medication: Drug(s) name, dose and date of
therapy started, indication of use, seriousness and outcome.
 Reporter: Name and address, date of report.
Guidelines on adr reporting

More Related Content

What's hot

Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...AbhishekJoshi312
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and AdvantagesUrvashi Shakarwal
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESanju Kaladharan
 
Guidelines For ADR Reporting.pptx
Guidelines For ADR Reporting.pptxGuidelines For ADR Reporting.pptx
Guidelines For ADR Reporting.pptxSohamChakrabarti6
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicalsShivam Diwaker
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsDeepak Kumar
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxRushikeshTidake
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingSanchit Dhankhar
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submissionShivanshu Bajaj
 
regulatory perspectives of clinical trails
regulatory perspectives of clinical trails regulatory perspectives of clinical trails
regulatory perspectives of clinical trails Pankaj Maurya
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies SonaliJain736101
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).helasri gummadi
 
Free radical-pharmacology
Free radical-pharmacologyFree radical-pharmacology
Free radical-pharmacologysharad patange
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 

What's hot (20)

Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCE
 
Guidelines For ADR Reporting.pptx
Guidelines For ADR Reporting.pptxGuidelines For ADR Reporting.pptx
Guidelines For ADR Reporting.pptx
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicals
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
regulatory perspectives of clinical trails
regulatory perspectives of clinical trails regulatory perspectives of clinical trails
regulatory perspectives of clinical trails
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Free radical-pharmacology
Free radical-pharmacologyFree radical-pharmacology
Free radical-pharmacology
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 

Similar to Guidelines on adr reporting

How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyDrpradeepthi
 
triage ppt.pptx
triage ppt.pptxtriage ppt.pptx
triage ppt.pptxVermaG3
 
Detecting Reporting ADR.pptx
Detecting  Reporting ADR.pptxDetecting  Reporting ADR.pptx
Detecting Reporting ADR.pptxAjithJs2
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse eventsKatla Swapna
 
Quality Reporting of ADR
Quality Reporting of ADRQuality Reporting of ADR
Quality Reporting of ADRNazmiLianaAzmi
 
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and ChallengesAdverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and ChallengesClinosolIndia
 
ICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSKatalyst HLS
 
icsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdficsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdfdabloosaha
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionssantoshi sahu
 
Revision of adverse drug reactions.pptx
Revision of adverse drug reactions.pptxRevision of adverse drug reactions.pptx
Revision of adverse drug reactions.pptxRanitBag1
 
Pharmacovigilance by khaga
Pharmacovigilance by khagaPharmacovigilance by khaga
Pharmacovigilance by khagaKhadga Raj
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingRuella D'Costa Fernandes
 
Pharmacovigilance overview shraddha
Pharmacovigilance  overview shraddhaPharmacovigilance  overview shraddha
Pharmacovigilance overview shraddhaDr. Shraddha Bhange
 
Patient profile (Taking & Components)
Patient profile (Taking & Components)Patient profile (Taking & Components)
Patient profile (Taking & Components)Muhammad Arsal
 
Adverse drug reactions ADRs by AKSHAY KUMAR
Adverse  drug  reactions ADRs by AKSHAY KUMARAdverse  drug  reactions ADRs by AKSHAY KUMAR
Adverse drug reactions ADRs by AKSHAY KUMARAkshaya Kumar
 

Similar to Guidelines on adr reporting (20)

Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical Pharmacy
 
triage ppt.pptx
triage ppt.pptxtriage ppt.pptx
triage ppt.pptx
 
Detecting Reporting ADR.pptx
Detecting  Reporting ADR.pptxDetecting  Reporting ADR.pptx
Detecting Reporting ADR.pptx
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse events
 
adverse drug reactions management
adverse drug reactions  managementadverse drug reactions  management
adverse drug reactions management
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Quality Reporting of ADR
Quality Reporting of ADRQuality Reporting of ADR
Quality Reporting of ADR
 
Pharmacovigilance suresh
Pharmacovigilance  sureshPharmacovigilance  suresh
Pharmacovigilance suresh
 
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and ChallengesAdverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
 
ICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLS
 
icsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdficsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdf
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Revision of adverse drug reactions.pptx
Revision of adverse drug reactions.pptxRevision of adverse drug reactions.pptx
Revision of adverse drug reactions.pptx
 
Pharmacovigilance by khaga
Pharmacovigilance by khagaPharmacovigilance by khaga
Pharmacovigilance by khaga
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
Pharmacovigilance overview shraddha
Pharmacovigilance  overview shraddhaPharmacovigilance  overview shraddha
Pharmacovigilance overview shraddha
 
Patient profile (Taking & Components)
Patient profile (Taking & Components)Patient profile (Taking & Components)
Patient profile (Taking & Components)
 
Adverse drug reactions ADRs by AKSHAY KUMAR
Adverse  drug  reactions ADRs by AKSHAY KUMARAdverse  drug  reactions ADRs by AKSHAY KUMAR
Adverse drug reactions ADRs by AKSHAY KUMAR
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 

More from SaiLakshmi110

Evaluation of cosmetic products
Evaluation of cosmetic productsEvaluation of cosmetic products
Evaluation of cosmetic productsSaiLakshmi110
 
In-vivo; Permeability methods
In-vivo; Permeability methodsIn-vivo; Permeability methods
In-vivo; Permeability methodsSaiLakshmi110
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatographySaiLakshmi110
 
Biological test and assay of Antivenom
Biological test and assay of AntivenomBiological test and assay of Antivenom
Biological test and assay of AntivenomSaiLakshmi110
 
Systems of human body
Systems of human bodySystems of human body
Systems of human bodySaiLakshmi110
 
Industrial designs in IPR
Industrial designs in IPRIndustrial designs in IPR
Industrial designs in IPRSaiLakshmi110
 
Geographical indications
Geographical indicationsGeographical indications
Geographical indicationsSaiLakshmi110
 
Types of oral controll drug delivery system
Types of oral controll drug delivery system Types of oral controll drug delivery system
Types of oral controll drug delivery system SaiLakshmi110
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery systemSaiLakshmi110
 
Targeted drug delivery system
Targeted drug delivery systemTargeted drug delivery system
Targeted drug delivery systemSaiLakshmi110
 

More from SaiLakshmi110 (13)

Evaluation of cosmetic products
Evaluation of cosmetic productsEvaluation of cosmetic products
Evaluation of cosmetic products
 
In-vivo; Permeability methods
In-vivo; Permeability methodsIn-vivo; Permeability methods
In-vivo; Permeability methods
 
Pesticide cycle
Pesticide cyclePesticide cycle
Pesticide cycle
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Biological test and assay of Antivenom
Biological test and assay of AntivenomBiological test and assay of Antivenom
Biological test and assay of Antivenom
 
Systems of human body
Systems of human bodySystems of human body
Systems of human body
 
New plant varieties
New plant varietiesNew plant varieties
New plant varieties
 
Industrial designs in IPR
Industrial designs in IPRIndustrial designs in IPR
Industrial designs in IPR
 
Geographical indications
Geographical indicationsGeographical indications
Geographical indications
 
Utility models
Utility modelsUtility models
Utility models
 
Types of oral controll drug delivery system
Types of oral controll drug delivery system Types of oral controll drug delivery system
Types of oral controll drug delivery system
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Targeted drug delivery system
Targeted drug delivery systemTargeted drug delivery system
Targeted drug delivery system
 

Recently uploaded

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayMakMakNepo
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 

Recently uploaded (20)

Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Rapple "Scholarly Communications and the Sustainable Development Goals"
Rapple "Scholarly Communications and the Sustainable Development Goals"Rapple "Scholarly Communications and the Sustainable Development Goals"
Rapple "Scholarly Communications and the Sustainable Development Goals"
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up Friday
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 

Guidelines on adr reporting

  • 1. Guidelines on ADR reporting Presented by; K. Sai Lakshmi B-Pharmacy, final year, (2016-2020) Balaji College of Pharmacy.
  • 2. A.PATIENT INFORMATION B.SUSPECTED DRUGS C.SUSPECTED ADVERSE DRUG REACTION D.OTHER MEDICATIONS E.REPORTER
  • 3. A. PATIENT INFORMATION; 1.Patient Details  Patient name or initials: A reporter should mention the name of the patient or initials of a patient. For e.g.: Ngawang Dema or ND (whichever is convenient).  Age at time of event or date of birth: A reporter must report either the date of birth or age of the patient at the time the event or reaction occurred.  Sex: A reporter must mention the gender of the patient.  Weight: If known, the weight of the patient should be in kilograms(kg).
  • 4. 2. Relevant tests/Laboratory data  A reporter must mention any laboratory data (if available). 3. Other Relevant history  A reporter must mention any relevant history pertaining to the patient including pre-existing medical conditions e.g.: Allergies, pregnancy, alcohol use, hepatic or renal dysfunction. B. SUSPECTED DRUGS;  It may be one drug or more than one drug.  The details of suspected medications such as the drug name (brand or generic name), manufacturer, batch no / lot no, expiry date, dose used, route used, dates of therapy started and stopped, and indication of use must be provided by the reporter.
  • 5. C. SUSPECTED ADVERSE DRUG REACTION; 1. Describe reaction and any treatment given:  A reporter must briefly describe the event in terms of nature, localization etc. For eg; patient developed rash over upper and lower limbs.  The reporter must be also indicate if any treatment is given againist the Suspected Adverse Drug Reaction.  Reporter must also mention if the suspected drugs was withdrawn or continued.  Date of reaction started; A reporter must the date on which the reaction was first occurred.  Date of reaction stopped; If the reaction recovered, the date on which the reaction recovered should be reported.  Outcomes: The reporter must tick the outcomes of the event as; Recovered- if the patient has recovered from the event Recovering- if the patient is recovering from the existing adverse event Continuing-if the patient is continuing to have the symptoms of the adverse event which occurred.
  • 6. 2. Seriousness of the reaction:  If any event is serious in nature, a reporter must selected the appropriate reason for seriousness e.g.:  Death-if the patient died due to the adverse event  Hospitalization/prolonged-if the adverse event led to hospitalization or increased the hospital stay of the patient.  Life-threatening-if patient was at substantial risk of drying because of the adverse event.  Significant Disability-if the adverse event resulted in a substantial disruption of a person`s ability to conduct normal life functions.  Congenital anomaly-if exposure of drug prior to conception or during pregnancy may have resulted in an adverse outcome in the child.  Other medically significant- when the event does not fit the other outcomes, but the event may put the patient at risk and may require medical or surgical intervention to prevent one of the other outcomes.
  • 7. D. OTHER MEDICATIONS;  A Reporter should include all the details of concomitant drugs including self medication, Over the Counter medication, herbal remedies with therapy dates(start and stop date). E. REPORTER;  Name and Professional address: A reporter must mention his/her name and professional address on the form. The identity of the reporter will be maintained confidential if necessary.  Date of report: Mention the date on which he/she reported the adverse event.
  • 8. NOTE: For quality reporting, all the above mentioned fields are essential. In case of incomplete information, the reporter must take care that at least mandatory fields are present. Following are the mandatory fields for a valid case report and are marked with asterisk on the form:  Patient information: initials, age at onset of reaction, gender.  Suspected adverse reaction: A reaction terms, date of onset of reaction.  Suspected medication: Drug(s) name, dose and date of therapy started, indication of use, seriousness and outcome.  Reporter: Name and address, date of report.